image: Summary of key findings from study. This material relates to a paper that appeared in the Aug. 28, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by A. Singanayagam at Imperial College London in London, UK; and colleagues was titled, "Inhaled corticosteroid suppression of cathelicidin drives dysbiosis and bacterial infection in chronic obstructive pulmonary disease." view more
Credit: Aran Singanayagam, Ph.D.